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West Nile virus (WNV), the leading cause of viral encephalitis in the United States, is an arthropod-transmitted member of the family
Flaviviridae. We have explored the interaction of this positive-strand RNA virus with signaling pathways involved in induction of the host’s
innate immune response. Phosphorylation of STAT-1 in response to interferon (IFN) treatment and the ability of IFN to establish an antiviral
state were reduced in WNV replicon-bearing cell lines. Similarly, the activation of IRF3 and stimulation of IFN-h transcription in response to
the double-stranded RNA (dsRNA) mimetic poly(I:C) were inhibited in replicon-bearing and WNV-infected HeLa cells. In contrast, WNV
replicons did not affect IRF3 activation by Sendai virus infection, suggesting that not all IRF3 activating pathways are inhibited by WNV.
Taken together, these findings demonstrate that WNV replication in cultured cells interferes with both the response to IFN and synthesis of
IFN-h in response to dsRNA.
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Members of the Flavivirus genus are among the most
important arthropod-transmitted disease agents. Dengue
virus (DV) infects up to 50 million people a year and
Japanese encephalitis virus (JEV) causes over 50,000 cases
of severe disease annually. West Nile virus (WNV), a close
relative of JEV, has caused thousands of cases of neuro-
logical disease in the US since its introduction in 1999.
Viruses in the Flavivirus genus are characterized by a
single-stranded RNA genome that encodes all of its proteins
as part of a single long polyprotein that is cleaved by viral
and host proteinases to produce structural proteins (C, prM/0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.07.021
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University, Raleigh, NC 27695-7615, USA.M, and E) and nonstructural proteins (NS1–5) that are
intimately associated with the endoplasmic reticulum of the
host cell (Lindenbach and Rice, 2003).
Encephalitis is a rare outcome of infections with JEV or
WNV, but both viruses are significant public health threats.
Multiple parts of the host’s immune response appear to be
critical for controlling flavivirus infections. Studies on
flavivirus-induced disease in mice that have specific deficits
in immune function have demonstrated that interferon (IFN)
receptors (Johnson and Roehrig, 1999; Lobigs et al., 2003),
antibody production (Diamond et al., 2003), and Toll-like
receptor 3 (TLR3) (Wang et al., 2004) are important for
modulating infection. These studies are consistent with early
reports demonstrating that treatment of animals with IFN
(Brooks and Phillpotts, 1999; Pinto et al., 1990) or IFN-
inducing drugs (Stephen et al., 1977; Taylor et al., 1980)
prior to infection can reduce signs of flavivirus disease, and
that animals treated with immunosuppressive drugs develop
severe disease following flavivirus challenge (Nathanson
and Cole, 1970). In agreement with these findings, patients005) 77 – 87
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istration of drugs to prevent rejection of transplanted organs
are at greater risk of developing severe disease following
WNV infection (Ravindra et al., 2004).
Over the last few years, there has been an increased
appreciation of the number of cellular components that
recognize pathogen-associated molecular patterns (PAMP)
of microbes and the pathways that are triggered by PAMP
recognition. These recognition molecules include the family
of Toll-like receptors (TLRs), which includes the dsRNA-
specific TLR3 (Yamamoto et al., 2002), as well as TLRs
that recognize DNA, protein, and carbohydrate-based
PAMPs. However, other molecules, including protein kinase
R (PKR) (Diebold et al., 2003) and the RNA helicases RIG-
I (Yoneyama et al., 2004) and mda-5 (Andrejeva et al.,
2004), have recently been added to the list of host-cell
proteins that signal the presence of pathogens by recogniz-
ing their PAMPs.
Several PAMP-triggered pathways stimulate IFN syn-
thesis via activation of IFN regulatory factor 3 (IRF3), a
resident cytoplasmic protein whose phosphorylation results
in dimerization and nuclear translocation (Fitzgerald et al.,
2003). Recent work on hepatitis C virus (HCV), a member
of the family Flaviviridae, has demonstrated that the HCV
NS3/4A-proteinase prevents phosphorylation of IRF3,
suggesting that disruption of IRF3 activation is important
for establishment of infection by HCV (Foy et al., 2003).
The importance of IRF3 activation in WNV infection has
also been recently shown (Fredericksen et al., 2004).
Although these studies reported that IRF3 activation
occurred relatively late in WNV-infected cells, cells from
IRF3/ mice produced larger WNV plaques and released
WNV for longer periods of time than wild-type murine cells
(Fredericksen et al., 2004).
Infection with DV (Munoz-Jordan et al., 2003), JEV (Lin
et al., 2004), and WNV (Guo et al., 2005; Liu et al., 2005)
interferes with the Jak-STAT signal transduction pathway,
suppressing the cell’s response to IFN. In addition, WNV
subgenomic replicons can also interfere with IFN treatment
(Guo et al., 2005; Liu et al., 2005; Rossi et al., 2005). In our
WNV replicon studies, we have shown that Huh7 cells
harboring WNV display a decreased response to IFN
(relative to wild-type cells) although long-term IFN treat-
ment can cure the cells of their replicons (Rossi et al., 2005).
Interestingly, other groups have reported that HepG2 cells
(Liu et al., 2005) and HeLa cells (Guo et al., 2005)
harboring replicons derived from Kunjin virus (an Austral-
ian subtype of WNV) are resistant to IFN curing. There are
several possible reasons for the differences between these
studies, that could be due to differences in cell types or
types of replicon RNA utilized. Interestingly, high-level
plasmid transfection-mediated expression of DV (Jones et
al., 2005; Munoz-Jordan et al., 2003) and Kunjin virus (Liu
et al., 2005) nonstructural proteins strongly suppresses
STAT activation, whereas the expression of the analogous
WNV proteins at low levels by replicons adapted to be non-cytopathic in Huh7 cells, have more modest effects on
suppression of the IFN response (Rossi et al., 2005).
Here, we examine several human cell lines harboring
WNV replicons, and demonstrate that the same replicon
can display different abilities to alter IFN-induced gene
expression in different cell lines. In addition, we
demonstrate that the presence of replicons or WNV alters
the ability of poly(I:C) to stimulate the IFN-h promoter
in human cells, and provide evidence that this action
results from interference with TLR3-mediated IRF3
activation.Results
WNV replicons interfere with IFN-activated STAT1
signaling
Several laboratories have shown that infection with
flaviviruses or presence of flavivirus replicons can interfere
with the ability of IFN to induce an antiviral state (see
Introduction). We have previously reported a WNV
replicon-bearing Huh7 cell line (Huh7 cl 1.1) (Fig. 1) and
a derivative of this cell line, which was cured of the WNV
replicon RNA by repeated passage in the presence of IFN
(Huh7 cured). In these same studies, we demonstrated that
replicon-bearing Huh7 cl 1.1 cells were more resistant than
their cured derivatives to IFN-induced gene activation
(Rossi et al., 2005). To further analyze this interference
with IFN action, we demonstrate in Fig. 2 that replicon-
bearing Huh7 cl 1.1 cells are more resistant to the
establishment of an IFN-induced antiviral state than their
cured derivatives. Pretreatment with larger amounts of IFN
is needed to prevent plaque formation by either DV2 (Fig.
2A) or VSV (Fig. 2B) on the Huh7 cl 1.1 cell line compared
to its cured derivative. Interestingly, this resistance is not
complete, IFN was able to prevent formation of infectious
foci by these viruses in the presence of replicon expression,
but approximately 5-fold more IFN was needed to reduce
infectious focus formation on replicon-bearing cells than on
the matched cured cells (Figs. 2A, B). Analysis of IFN-
stimulated STAT1 phosphorylation in these two cell lines
demonstrated a parallel 5-fold reduction in STAT1 phos-
phorylation in the replicon-bearing cell line (Fig. 2C). The
lower panel of Fig. 2C demonstrates that the presence of the
replicon had no effect on the resting levels of STAT1 in
Huh7 cells.
Different cell lines express different levels of replicon and
display different sensitivities to IFN
Our previous studies with replicon-bearing Huh7 cl 1.1
cells demonstrated that these cells were able to be cured of
the replicon by multiple passages in the presence of IFN
(Rossi et al., 2005), in apparent contrast to studies from
other investigators showing that flavivirus proteins and/or
Fig. 1. Structure of WNV replicons used in this study. WNV replicons are deleted for the region encoding the structural proteins C, prM, and E with the
exception of a small portion of C, containing a cis-acting RNA replication signal and the transmembrane region of E serving as the signal sequence for NS1.
The 3V UTRs contain a minipolyprotein coding cassette consisting of the EMCV internal ribosomal entry site (IRES), a reporter gene (HIV tat or firefly
luciferase), followed by the autocatalytic FMDV 2A protease and neomycin phosphotransferase. Huh7 cl 1.1 and L293 cl 2.4 cell lines were cloned from
cultures transfected with in vitro transcribed replicon RNA. HeLa cl 1.1.1 cells were cloned from cultures infected with replicons transpackaged out of Huh7 cl
1.1 cells (Scholle et al., 2004). Huh7 cl 26.5.1 cells were selected after electroporation of Huh7 cultures with total RNA isolated from BHK cl 26 cells (Rossi et
al., 2005).
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Introduction). The data shown in Fig. 2 support and extend
our findings (demonstrating incomplete inhibition of
STAT1-mediated signaling), but do not explain why our
replicon-bearing Huh7 cells responded differently to IFN
treatment than HeLa cells (Guo et al., 2005) or Hep2 cells
(Liu et al., 2005) bearing Kunjin virus replicons. To address
this issue, we established replicon-bearing cell lines, using
different cellular backgrounds, replicons with slightly
different structures, and cell culture-adapted replicons.
L293 cl 2.4 cells were obtained by transfection with in
vitro-synthesized transcripts of the same replicon-encoding
plasmid used to establish Huh7 cl 1.1 cells (WNR NS1–5
ET2AN, Fig. 1) (Rossi et al., 2005). As observed for Huh7
cells, the frequency of obtaining L293 cells capable of
forming colonies in G418 was quite low, consistent with a
requirement for acquisition of a cell culture-adaptation in
the replicon RNA, similar to that we had observed in other
primate cells (Rossi et al., 2005). The exact nature of these
cell culture adaptive mutations will be described in detail
elsewhere. The cell culture-adapted replicon contained in
the Huh7 cl 1.1 cell line was packaged into WN virus-like
particles (VLPs), using our recently described Sindbis virus
replicon-based transpackaging system (Scholle et al., 2004).
After infection of HeLa cells with these VLPs and selection
with G418, a very high proportion of the replicon
‘‘infected’’ cells produced G418-resistant colonies. One of
these, HeLa cl 1.1.1, was selected for further studies. A
second Huh7 cell line, Huh7 cl 26.5.1 containing replicon
WNR NS1–5 ELuc 2AN (Fig. 1) (Rossi et al., 2005) was
generated by electroporation of RNA isolated from BHK
cell clone 26.5 (Rossi et al., 2005) containing this replicon.
All replicon-bearing cell lines stably maintained their
replicon RNAs in the presence of G418. Cured derivatives
of the L293 cl 2.4 and HeLa cl 1.1.1 cells were obtained by
repeated treatment with 200 U/ml of IFN (see Materials and
methods; attempts were not made to cure the Huh7 cl 26.5.1
cells).The data in Fig. 3A demonstrate that these cell lines
express different levels of replicon-encoded antigen, with
the HeLa cell line expressing levels over 10 times as high as
the Huh7 cells. The antigen levels in the other cell lines
were intermediate between the HeLa and Huh7 cl 1.1 cells.
Interestingly, these cells displayed very different properties
when treated with IFN for 3 days (Fig. 3B). These
experiments revealed the same level of clearance for the
Huh7 cl 1.1 cells that we reported previously (Rossi et al.,
2005) and demonstrated that most of the viral antigen was
cleared from Huh 7 cl 26.5.1 cells, albeit not quite as
efficiently as for Huh7 cl 1.1 cells. WNV antigen was also
efficiently cleared from the ‘‘high-expressing’’ HeLa cell
clone 1.1.1 during a 72-h IFN treatment. Interestingly, these
concentrations of IFN did not have any detectable effect on
the level of antigen in the L293 cl 2.4 cells (Fig. 3B),
suggesting that the L293 cells showed a greater resistance to
IFN, the replicons in these cells were resistant to IFN, and/or
replicons were more effective at preventing IFN action in
this cell type. Eventually, repeated treatment with 200 U/ml
of IFN did permit the generation of a cured L293 cell culture
(see above and Materials and methods), indicating that the
L293 cl 2.4 cells were not completely resistant to long-term
IFN action.
To investigate IFN-induced transcription in these cells,
L293 cl 2.4, HeLa cl 1.1.1, and Huh7 cl 1.1 cells (and
their cured derivatives) were evaluated using a reporter
plasmid that contains multiple copies of the IFN-
stimulated response element (ISRE) of ISG56 directing
expression of luciferase (pISRE-Luc; see Materials and
methods). The results of these experiments, shown in
Fig. 3C, confirmed our previous results with the Huh7
cell lines, showing an inhibition of IFN-stimulated
promoter activation in replicon-bearing cells (Rossi et
al., 2005), and demonstrated that the replicon-induced
repression observed in L293 cells was much greater,
consistent with their increased resistance to IFN-mediated
WNV antigen removal by IFN treatment (Fig. 3B). In
Fig. 2. Differences in IFN functional activity and STAT1 activation in Huh7
cl 1.1 cells and its cured derivative. (A, B) Reduction in plaque formation
by DV2 or VSV in these cell types. Duplicate monolayers of cells were
treated for 18 h with the indicated concentrations of IFN, infected with DV2
(A) and VSV (B), and plaques were detected 16 h (VSV) or 72 h (DV2)
later as described in Materials and methods; the results are displayed as
percent of plaques obtained on untreated monolayers. Average plaque
numbers obtained on untreated monolayers were as follows: DEN type 2:
Huh7 cured: 35, Huh7 cl 1.1: 48.5; VSV: Huh7 cured: 26, Huh7 cl 1.1: 29.
As expected, plaque sizes decreased with increasing concentrations of IFN.
(C) Levels of phosphorylated STAT1 (P-STAT1) and STAT1 in a Western
blot prepared with lysates recovered from cells treated with the indicated
concentrations of IFNa for 30 min (see Materials and methods).
Fig. 3. Evaluation of replicon levels and IFN responsiveness in various
replicon-bearing cells. (A) WNV antigen levels in replicon-bearing
monolayers of Huh7, L293, and HeLa cells as detected by ELISA
(expressed as OD 450). (B) Levels of antigen in monolayers of cells
treated for 72 h with 0, 12.5, 50, or 200 U/ml of IFN-a (expressed as % of
antigen detected in untreated monolayers). (C) IFNa-induced activation of
pISRE reporter plasmids transfected into replicon-bearing cells (Huh7 cl
1.1, L293 cl 2.4, and HeLa cl 1.1.1) cells and their cured derivatives. 24 h
after transfection, cells were treated with 0, 0.8, 4, or 20 U/ml of IFNa for
16 h, harvested and luciferase and h-gal activities were determined (data are
expressed in terms of luciferase activity relative to h-gal activity from a co-
transfected h-gal expressing plasmid, see Materials and methods).
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modest resistance to IFN-induced ISRE activation rela-
tive to cured cells. This difference was most readily seen
at low to intermediate concentrations of IFN, consistent
with our previously reported Huh7 cell data (Rossi et al.,
2005). Both HeLa cell lines displayed very poor
activation of the pISRE reporter, as predicted from
previous studies showing that HeLa cells express low
levels of ISGF3 (Levy et al., 1990). However, as
mentioned above, HeLa cells could be cured of the
WNV replicon RNA after prolonged passage in presence
of IFN despite their modest transcriptional response to
short-term IFN treatment.
To investigate whether the unique properties of the L293
cl 2.4 cell line were due to the properties of the replicon itcontained or the specific cell clone obtained during G418
selection, total RNA isolated from this cell line was re-
transfected into Huh7 cells, and a G418-resistant clone
(Huh7 cl 2.4.1) was isolated. When subjected to IFN
treatment, WNVantigen was cleared from the Huh7 cl 2.4.1
cells within 3 days (results not shown), in a manner
indistinguishable from the Huh7 cl 1.1 cells (Fig. 3B).
Thus, the ability of L293 cl 2.4 cells to resist curing appears
to reflect a specific sensitivity of these cells to replicon-
mediated effect(s) since the replicon recovered from this cell
line does not display strong IFN-suppressing activities when
re-introduced into Huh7 cells. Furthermore, the IFN-
resistance of replicon-bearing cells is not simply related to
levels of replicon expression (since HeLa cells have the
highest level of antigens but readily cure). Taken together,
these studies indicate that the ability of WNV replicon-
bearing cells to respond to IFN is dependent on the cell type,
helping to reconcile differences in IFN sensitivity of
Fig. 4. HeLa cell responses to WNV infection and dsRNA treatment. (A)
Fold induction in reporter gene activity detected 24 and 48 h post-infection
with WNV. HeLa cells were co-transfected with reporter constructs in
which either the IFN-h promoter (IFN-b Luc) or four copies of an IRF3
binding site (4xIRF3 Luc) drive expression of luciferase and a h-gal
expression construct. Cells were infected with WNV for 24 h or 48 h,
harvested and luciferase and h-gal activity were determined. Results are
expressed as fold induction of relative luciferase activity over mock-
infected cells. (B) Poly(I:C) response is mediated through TLR3. HeLa cells
were transfected with either a control siRNA (specific for GAPDH) or a
TLR3-specific siRNA, subsequently co-transfected with the IFNb-Luc
reporter construct and h-gal expression plasmid, and were left unstimulated,
treated with poly(I:C) for 4 h, or infected with SenV for 8 h. Data show
luciferase activity normalized to h-gal activity. (C) Semiquantitative RT-
PCR analysis of GAPDH and TLR3 mRNA levels in HeLa cl 1.1.1, cured
HeLa, and wt HeLa cells transfected with either TLR3 or GAPDH siRNAs.
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WNV replication alters the ability of cells to respond to
dsRNA
Viruses have evolved multiple mechanisms to evade the
innate immune response. Thus, we were interested to
determine whether WNV was also able to interfere with
IFN induction. For these studies, we focused on recog-
nition of dsRNA as a PAMP that can stimulate IFN
transcription through two distinct pathways, TLR3-medi-
ated IRF3 activation and IRF3 activation through RNA
helicases such as RIG-I or mda-5 (see Introduction). To
activate IRF3 through these respective pathways, we chose
poly(I:C), a dsRNA mimetic, added to the culture medium
for stimulation of TLR3 (Yamamoto et al., 2002) and
infection with Sendai virus (SenV) to stimulate RNA
helicase-mediated IRF3 activation (Elco et al., 2005; Li et
al., 2005a). To monitor IRF3 activation, reporter assays
were used to determine luciferase expression driven by
either the IFN-h promoter (plasmid IFN-B pGL3) (Lin et
al., 2000) or a tetramer of the IRF3 binding site from this
promoter (using plasmid p4xIRF3-Luc) (Ehrhardt et al.,
2004). Huh7 and HEK 293 cells reportedly do not express
detectable levels of TLR3 (Elco et al., 2005; Li et al.,
2005a) and did not respond to poly(I:C) in our hands (data
not shown). In HeLa cells, WNV infection by itself
stimulated both IFN-h promoter activity and activation of
the IRF3 reporter plasmid (Fig. 4A), consistent with the
work of Fredericksen et al. showing that WNV infection
activates IRF3, resulting in the transcription of IFN-h
(Fredericksen et al., 2004). Similarly, HeLa cells also
proved competent for IFN-h promoter induction and
induction of the IRF3 reporter construct by either poly(I:C)
treatment or SenV infection (Fig. 4B and data not shown).
To demonstrate that poly(I:C) signals through TLR3 in
HeLa cells, cells were transfected with siRNAs specific for
either TLR3 or GAPDH (used as a negative control). The
TLR3 siRNA greatly diminished poly(I:C)-induced IFN-h
promoter activation, whereas SenV-induced transcription
was not affected (Fig. 4B). Semiquantitative RT-PCR
analysis showed specific reduction of TLR3 or GAPDH
mRNA in cells transfected with the respective siRNAs
(Fig. 4C) and furthermore demonstrate that the presence of
WNV replicon RNA does not alter TLR3 mRNA levels.
Based on these studies, HeLa cells were chosen as a
suitable model cell line in which to investigate if WNV
interferes with IFN gene transcription.
Following poly(I:C) treatment, the cured derivative of
the HeLa cl 1.1.1 replicon cell line responded with
transcriptional activation of Luc expression from both the
IFN-h as well as the 4xIRF3 reporter constructs (Fig.
5A). In contrast, replicon-bearing HeLa cl 1.1.1 cells did
not respond to poly(I:C) treatment (Fig. 5A). The same
results were obtained with another independently derivedreplicon-bearing HeLa cell line (cl 2.1, data not shown),
demonstrating that inhibition of poly(I:C) signaling is not
cell clone specific. To demonstrate that the effects
observed in replicon-bearing cells were also found in
virus-infected cells, HeLa cells were challenged with
Fig. 5. (A) Effect of poly(I:C) treatment on IFNhpGL3 and p4xIRF3-Luc
reporter expression in replicon-bearing HeLa cl 1.1.1 cell and its cured
derivative. Data are expressed as relative luciferase activity, normalized to
h-gal activity. (B) Effect of poly(I:C) challenge on mock-infected or virus-
infected cells. Cells were transfected with reporter constructs and h-gal
expression plasmid and subsequently infected with WNV at an MOI of 10.
At the indicated times, cells were treated with poly(I:C) for 4 h or left
untreated. Data are presented as relative luciferase activity, normalized to h-
gal activity. P values were calculated using Student’s t test. (C) Transcrip-
tional activation of either the IFN-h or IRF3 responsive promoter after
SenV infection of HeLa cl 1.1.1 or cured HeLa cells. Cells plated in 24-well
plates were transfected with reporter constructs and after 24 h infected with
200 HA units of SenV for 8 h.
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infection with WNV. HeLa cells infected with WNV at
an MOI of 10 for 12, 24, or 48 h showed a dramaticinhibition of IFN-h promoter activation upon challenge
with poly(I:C) compared to mock-infected cells (Fig. 5B).
These results strongly suggest that WNV RNA repli-
cation and/or protein expression interferes with poly(I:C)-
mediated gene induction. In contrast, IRF3-dependent
promoter induction was indistinguishable when either
replicon-bearing or cured HeLa cells were challenged with
SenV (Fig. 5C), a paramyxovirus that is able to activate
IRF3 in the absence of TLR3 (Andrejeva et al., 2004; Elco
et al., 2005; Li et al., 2005a; Yoneyama et al., 2004). Thus,
WNV replicons do not block all types of IRF3 activation in
HeLa cells, but rather specifically suppress the poly(I:C)-
mediated activation of IRF3.
WNV infection blocks poly(I:C)-induced nuclear
translocation of IRF3
After its phosphorylation by noncanonical Inb kinases
IKKE and TBK-1, IRF3 homodimerizes, followed by its
translocation into the nucleus. To determine whether nuclear
import might be altered in WNV repRNA-bearing cells,
immunofluorescence analysis was performed on the unsti-
mulated, poly(I:C)-treated and SenV-infected HeLa cl 1.1.1.
cell line and its IFN-cured derivative (Fig. 6A). In
unstimulated cells, IRF3 is localized predominantly in the
cytoplasm. Upon poly(I:C) stimulation, almost complete
IRF3 translocation into the nucleus was observed 1 to 2 h
after addition of poly(I:C) in cured HeLa cells. SenV
induced efficient IRF3 translocation within 8 h of infection.
In contrast, poly(I:C) treatment did not result in IRF3
nuclear translocation in HeLa cl 1.1.1 cells in agreement
with the block in IRF3-dependent transcription described
above. In confirmation of the reporter assay data, SenV
infection was able to induce IRF3 translocation in both
cured and repRNA bearing cells (Fig. 6A).
To allow side-by-side comparison of IRF3 subcellular
localization in both infected and uninfected cells in the same
microscope field, HeLa cells were infected with WNV at a
low MOI (0.25), and stimulated with poly(I:C) 12 h after
infection or left untreated (Fig. 6B). WNV antigen was
detected by immunofluorescence with a WNV anti-E anti-
body (red) and IRF3 was detected with an IRF3-specific
polyclonal antibody (green). In the absence of poly(I:C)
treatment, IRF3 was localized primarily to the cytoplasm in
both infected and uninfected cells. In contrast, after
poly(I:C) stimulation, IRF3 was translocated to the nucleus
in uninfected cells only. These results demonstrate that,
already early in infection, WNV blocks poly(I:C)-induced
IRF3 nuclear translocation.
WNV inhibits IRF3 dimerization
To gain further insight into the mechanisms respon-
sible for the observed IRF3-dependent transcriptional
suppression, IRF3 protein levels were compared in a
Western blot of lysates from cured HeLa and HeLa cl
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IRF3 from replicon-bearing cells (Fig. 7A), in support of
the clearly visible nuclear IRF3 staining in SenV-infection
of both cell lines (see Fig. 6A). IRF3 dimerization in
response to activating stimuli was investigated using
native PAGE, followed by IRF3-specific Western blot. In
cured HeLa cells, the IRF3 dimer was readily detected
upon stimulation with both poly(I:C) and infection with
SenV, whereas only SenV infection induced IRF3
dimerization in HeLa cl 1.1.1 cells (Fig. 7B). Twelve
hours after infection, the IRF3 dimer was detected in
lysates from mock-infected, poly(I:C)-treated cells only,
but not in cells infected with WNV or WNV-infected
cells treated with poly(I:C) (Fig. 7C). This sameFig. 7. (A) Western blot image showing levels of IRF3 and h-actin in
lysates of HeLa cl 1.1.1 and its cured derivative. (B) IRF3 dimerization in
the HeLa cl 1.1.1 cell line and its cured derivative after poly(I:C)
stimulation for 2 h or SenV infection for 8 h. Cell lysates were analyzed
by native PAGE and IRF3 was detected by Western blot with a rabbit
polyclonal anti-IRF3 serum. (C) IRF3 dimerization in mock-infected and
WNV-infected cells with and without poly(I:C) stimulation. HeLa cells
were infected with an MOI of 10 for 12 h and treated with poly(I:C) where
indicated for 2 h. IRF3 monomers and dimers were visualized by Western
blot following native PAGE. As a loading control, h-actin was detected in
these same cell lysates by Western blot.
Fig. 6. (A) Confocal micrographs showing IRF3 translocation in response
to poly(I:C)- or SenV-challenge of cured and replicon-bearing HeLa cells.
IRF3 was stained using indirect immunofluorescence 1 h after treatment
with poly(I:C) or 8 h after infection with SenV (see Materials and methods).
(B) Effect of a 2-h poly(I:C) treatment on IRF3 (green) translocation in
HeLa cells 12 h after infection (or mock-infection) with a low MOI of
WNV (MOI 0.25) (stained red).inhibition was also found at later time points (data not
shown). These data indicate that the WNV-mediated
inhibition of IRF3-dependent transcription is not due to
a generalized shutdown of transcription but rather due to
a specific interference with poly(I:C)-mediated signal
transduction.Discussion
The initial immune response to microbial infection
includes immediate anti-microbial activities (often referred
to as innate immunity) as well as activities that dictate the
quality and quantity of the adaptive responses (Vivier and
Malissen, 2005). In most infections, innate and adaptive
immunity are triggered by host surveillance for PAMPs that
allows for appropriate responses to infection, but prevents
toxic responses (such as inflammation) in the absence of
infection. Pathogens, on the other hand, have developed
strategies to evade recognition and activation of host
defenses.
Previous work has shown that flaviviruses prevent one of
the most important secondary responses to intracellular
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cells to respond to type I IFN (see Introduction). In this
article, we have further characterized this inhibition by
demonstrating that depending on the cell line used, there are
differences in how effectively WNV replicons can suppress
the cell’s response to IFN treatment. Although these
findings are consistent with those demonstrating that IFN
is not always useful as a therapeutic for treating flavivirus
infections, it remains unclear how important virus-induced
inhibition of IFN action is for viral spread in vivo and
transmission in nature.
In addition to the reduction of IFN action as an important
aspect of a virus’ defense against the antiviral response,
some viruses have evolved to escape host-cell detection. In
the case of flaviviruses, one PAMP that is likely to be
involved in detection is dsRNA. To be effective triggers of
the anti-microbial response, PAMPs must be recognized in a
way that does not initiate an anti-microbial response in the
absence of a pathogen. Thus, receptors that recognize these
PAMPs must discriminate between host and pathogen
RNAs, possibly by surveillance for these activities in
different host-cell compartments (Boehme and Compton,
2004). Several different molecules (TLR3, PKR, RIG-I, and
mda-5) have been implicated in dsRNA recognition (see
Introduction).
In the case of WNV, replicon-bearing cells and virus-
infected cells display a reduced sensitivity to transcriptional
stimulation of IRF3 responsive promoters, a reduction of
nuclear translocation of IRF3, and a reduction of IRF3
dimerization when treated with the dsRNA mimetic,
poly(I:C). The poly(I:C)-induced activation of IRF3 and
IRF3-dependent transcriptional activation was dependent on
the presence of TLR3, suggesting that WNV interferes with
the TLR3 signaling pathway. In contrast, WNV replicons
did not interfere with SenV-induced IRF3 translocation,
dimerization, or stimulation of the IFN-h promoter. SenV
has recently been shown to induce gene activation
independent of TLR3, suggesting that SenV primarily
stimulates IRF3 through activation of RNA helicases RIG-
I or mda-5 (Elco et al., 2005; Li et al., 2005a). Although
these previously reported findings on the pathways activated
by SenV and the data presented in this paper support a
specific inhibition of TLR3 signaling by WNV, we cannot
exclude that WNV acts on other IRF3-activating pathways,
in a manner that is unable to suppress the strong IRF3-
activating activity of SenV. The WNV interference with
TLR3-mediated IRF3 activation we have observed could
result from interaction(s) of components with a subset of
signaling intermediates that are involved in specific PAMP
signaling pathways, so the effects may extend to other
pathways beyond those involving TLR3. Understanding
these mechanisms could yield insights into the importance
of these pathways (and their evasion) in flavivirus repli-
cation and pathogenesis. Furthermore, our finding that
WNV replicons, deleted for the structural protein coding
region, interfere with poly(I:C) signaling indicates that theeffect is due to the nonstructural proteins, the RNA
encoding this region, or the non-coding regions of the
virus, rather than the structural proteins or the RNAs
encoding their genes.
The importance of the TLR3 pathway in controlling viral
replication has recently been questioned in a paper that
demonstrated little, if any, effect of TLR3 deletion on the
pathogenesis of several viruses in mice (Edelmann et al.,
2004). However, a recent report by Fikrig and co-workers
demonstrated that TLR3-deficient mice display a difference
in their response to WNV infection (Wang et al., 2004).
Specifically, TLR3/ mice showed a higher peripheral
viral load, albeit reduced virus invasion into the CNS and
encephalitis. This latter effect was mimicked in TNF
receptor knockout mice, indicating that TLR3-mediated
induction of proinflammatory cytokines, such as TNFa
might be responsible, in part, for increases in permeability
of the blood–brain barrier, resulting in higher mortality in
TLR3-intact mice. TLR3 signaling activates both IRF3, as
well as NFnB, which in turn induces expression of multiple
proinflammatory cytokines. At this point, the exact roles
these different downstream effects might play in WNV
pathogenesis are not completely understood and warrant
further investigation. The finding that there was a modestly
reduced level of replication in the periphery of the TLR3-
intact mice may be important for WNV transmission in
nature, which requires high-viremias, and is unaffected by
the development of encephalitis in accidental hosts such as
horses or man. Interestingly, the viral protease of hepatitis C
virus (HCV), another member of the Flaviviridae, that
causes predominantly persistent infections, interferes with
both TLR3 signal transduction as well as IRF3 activation
mediated through RIG-I (Breiman et al., 2005; Foy et al.,
2005; Li et al., 2005b). The WNV-mediated interference
with IRF3 activation we have reported in this article was
observed early in infection, prior to infection-induced
activation of IRF3 (Fredericksen et al., 2004). Thus, this
mechanism of interference could have been acquired by the
virus to help spread in vivo, consistent with the increased
viral load reported in TLR3-deleted mice (Wang et al.,
2004).Materials and methods
Cell lines, plasmids, and viruses
Huh7 cells and Huh7 cl 1.1 cells harboring a WNV
replicon have been described (Rossi et al., 2005); L293 cells
were created by transfecting HEK293 cells (obtained from
R. Davey, UTMB) with the plasmid pLTR-SEAP (Yi et al.,
2002; obtained from M.-Y. Yi, UTMB) and selecting
transfected cells with blasticidin. HeLa cells were obtained
from S.M. Lemon (UTMB). Low-copy plasmids carrying
cDNAs encoding a WNV replicon containing a polyprotein
encoding HIV tat (or Luciferase) and E. coli neomycin
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al., 2005). Replicon RNAs were prepared from Swa-I
linearized plasmid DNA and introduced into cells by
electroporation (Rossi et al., 2005). In some cases, total
cellular RNA obtained from replicon-carrying cultures
(purified using RNaqueous; Ambion) was introduced into
cells by electroporation. Alternatively, replicons present in
established cell lines were encapsidated into VLPs by
transfection with a Sindbis replicon-based transpackaging
RNA expressing the WNV structural proteins (Scholle et al.,
2004) and VLPs were used to infect naı¨ve cells with VLPs.
Cells containing replicons were selected and maintained in
standard growth media containing 400–600 Ag/ml G418.
Cured derivatives of replicon-containing cells were obtained
by multiple passages of the replicon-carrying cultures in 200
U/ml of IFNa-LE (Sigma) in the absence of G418. The
resulting ‘‘cured’’ cultures (which represented bulk cultures)
were shown to be free of replicons by the absence of WNV
antigen using immunohistochemical staining (IHC) (Rossi
et al., 2005 and results not shown) and the inability to obtain
G418-resistant cells from cured cultures by re-application of
G418 (results not shown). Live WNV was obtained from a
molecular clone of a human 2002 isolate from Texas, that
was the source of the cDNAs used to generate all replicons
used in these studies (Rossi et al., 2005). A mouse brain-
adapted New Guinea C strain of DV type 2 (DV2) and the
Hazelhurst strain of the New Jersey serotype of vesicular
stomatitis virus (VSV) were obtained from R.B. Tesh
(UTMB) and grown in Vero cells. SenV was obtained from
Charles River labs.
IHC staining of viral plaques
Plaques formed by DV2 or VSVon cell monolayers were
stained as previously described (Rossi et al., 2005). Briefly,
following infection and incubation under a semi-solid
overlay, the monolayers were fixed and incubated with a
VSV- or DV2-specific murine hyper-immune ascitic fluid
(MHIAF; provided by R.B. Tesh), followed by a horse-
radish peroxidase (HRP)-conjugated anti-mouse antibody
(KPL). After secondary antibody incubation, the cells were
incubated with substrate for HRP (VIP Substrate Kit, Vector
Labs) until plaques were visible by eye.
Western blot analyses
Protein extracts prepared from cell monolayers by
incubation for 10 min on ice in lysis buffer (300 mM NaCl,
50 mM Tris–HCl, pH 7.6, 0.1% Triton X-100) were
clarified by centrifugation for 5 min at 13,000 rpm, and
protein contents were determined utilizing the DC Protein
Assay (Bio-Rad). Samples containing equal amounts of
protein were heated in LDS buffer (Invitrogen) containing
50 mM DTT, resolved on 4–12% Nu-PAGE gels (Invi-
trogen) and electroblotted onto PVDF membranes using
standard methods. Blots were stained with a monoclonalantibody specific for the pY701 peptide of STAT1 (Trans-
duction Labs, BD Pharmingen), a monoclonal antibody to
h-actin (Sigma), or rabbit anti-IRF3 antibodies (generously
supplied by M. David, UCSD) followed by an HRP-
conjugated goat antibody of the appropriate specificity
(KPL). Antibodies were diluted in blocking buffer (0.2% I-
Block, Tropix; 0.1% TWEEN 20, Sigma, diluted in PBS)
and the incubations were performed for at least 30 min at
room temperature. After incubation, the membranes were
washed and bound HRP was visualized with a chemilumi-
nescent detection system (ECL Plus; Amersham Bioscien-
ces). In the case of the pY701 blot, the blot was stripped and
re-probed with a monoclonal antibody specific for the N-
terminus of STAT1 (Transduction Labs). Native PAGE for
analysis of IRF3 dimer formation was performed as
previously described (Mori et al., 2004) using rabbit anti-
IRF3 antibodies for detection.
Measurement of WNV antigen in replicon-expressing cells
Replicon-harboring cell lines or their cured derivatives
were plated in 24-well plates at appropriate densities, and in
some cases, treated with IFN for up to 72 h. Cell lysates
were prepared as described above, diluted in lysis buffer to
yield identical concentrations of cell protein, and then
diluted 10-fold in carbonate–bicarbonate ELISA coating
buffer (Sigma) and used to sensitize Immunolon II plates
(Nunc) by overnight incubation at 4 -C. The plates were
blocked and incubated in an anti-WNV MHIAF, followed
by HRP-conjugated goat anti-mouse antibody (KPL), and
bound HRP was detected with a soluble ELISA substrate
(TMB; Sigma) and quantitated spectrophotometrically at
450 nm. In all cases, ELISA values were corrected for
background optical density detected in samples obtained in
parallel from cured cells; in some cases, values were
expressed in terms of the percent of the OD obtained from
parallel samples that were not treated with IFN.
Reporter assays
Poly(I:C)- or IFN-mediated activation of transcription
was measured by detecting reporter activity in cells trans-
fected with a mixture of equal amounts of pCMV h-gal
(Stratagene) and either pISRE-Luc (Stratagene), IFNh
pGL3 (obtained from J. Hiscott, McGill Univ., Montreal,
Canada), or p4xIRF3-Luc (obtained from Christina Ehr-
hardt, Universitatsklinikum, Dusseldorf, Germany), using
TransIT-LT1 Transfection Reagent (Mirus) or Lipofect-
amine plus (Invitrogen). Twenty-four to 48 h later, the cells
were treated for 16–24 h with media containing IFNa or
treated for 4 h with poly(I:C) (40 Ag/ml; Calbiochem).
Alternatively, cells were infected with 200 HA units of
SenV for 8 h. At the end of the treatment, cells were lysed in
reporter lysis buffer (Promega), containing 0.1% Triton X-
100, and assayed for luciferase (Luc) and h-galactosidase
(h-gal) activity using a Luc assay kit (Promega) and an
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dilution series of the appropriate purified enzyme to create a
standard curve. All assays were performed with at least
duplicate cell monolayers. All data are expressed in terms of
relative light units (RLU) of Luc normalized to h-gal
activity to compensate for variability in reporter plasmid
transfection efficiency between wells.
Immunofluorescence
Monolayers of cells were prepared in LabTek chamber
slides and treated with 40 Ag/ml poly(I:C) for 1 or 2 h,
infected with 200 HAU of SenV for 8 h, or infected at a
multiplicity of infection (MOI) of 0.25 with WNV for 12 h.
Following PBS rinsing, the cells were fixed in 4% paraf-
ormaldehyde, blocked with 2% BSA (Sigma), 5% NHS, and
10 mM glycine in PBS, permeabilized with 0.1% Triton X-
100 (Sigma), and then incubated with anti-IRF3 antiserum,
followed by FITC-labeled goat anti-rabbit antibody (South-
ern Biotechnology Associates). For double labeling, the
primary antibody incubation also contained a WNV E-
specific antibody (7H2, Bioreliance) and the secondary
antibody incubation also contained a Texas Red-labeled goat
anti-mouse antibody (KPL). Stained cells were analyzed with
a 1.0 Zeiss LSM 510 UV META Laser Scanning Confocal
Microscope at the UTMB Infectious Disease and Toxicology
Optical Imaging Core Facility.
siRNA transfection
The TLR-3 siRNA (targeted to GGTATAGCCAGC-
TAACTAG; Ambion) and a control siRNA specific for
GAPDH (Ambion) were transfected into cells using
Oligofectamine (Invitrogen) according to the manufacturer’s
specifications. SiRNAs were added at a concentration of
100 nM to wells containing 30,000 cells; 24 h later, reporter
plasmids were added as described above, and 24 h after that,
poly(I:C) was added as described above or cells were
infected with SenV as described.
RT-PCR analysis
Cells were lysed in Trizol LS reagent (Invitrogen) and
total cellular RNA was isolated according to the
manufacturer’s specifications. First-strand synthesis was
performed using Improm II reverse transcriptase (Prom-
ega), random hexamers as primers and 0.5 Ag of cellular
RNA as template in a 20-Al reaction. Amplification
reactions were carried out using 0.5 Al of cDNA template
and AccuTaq LA polymerase (Sigma). Primer sequences
were as follows:GAPDH Fw: 5V ACCACAGTCCATGCCATCAC 3V
Rev: 5V TCCACCACCCTGTTGCTGTA 3V
TLR3 Fw: 5V TCACTTGCTCATTCTCCCTT 3V
Rev: 5V GACCTCTCCATTCCTGGC 3VThe linear range for GAPDH amplification was deter-
mined at 25 amplification cycles. For TLR3, 35 cycles
were used.
Statistical analyses
Error bars in figures represent standard deviations of the
mean. P values in Fig. 6B were calculated using a two-tailed
paired Student’s t test. Values of P < 0.05 are considered
statistically significant.Acknowledgments
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